Sökning: WFRF:(Brewer Carole) > Exploring the link ...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 14640naa a2202305 4500 | |
001 | oai:lup.lub.lu.se:abfff1a4-5eb7-4fa1-bb7c-717d45d9b1fd | |
003 | SwePub | |
008 | 160401s2011 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:122911763 | |
009 | oai:DiVA.org:uu-156692 | |
009 | oai:DiVA.org:liu-69933 | |
024 | 7 | a https://lup.lub.lu.se/record/20942732 URI |
024 | 7 | a https://doi.org/10.1186/bcr28622 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1229117632 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-1566922 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-699332 URI |
040 | a (SwePub)lud (SwePub)kid (SwePub)uud (SwePub)liu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Martrat, Griseldau IDIBELL,University Med Centre Utrecht4 aut |
245 | 1 0 | a Exploring the link between MORF4L1 and risk of breast cancer |
264 | c 2011-04-05 | |
264 | 1 | b Springer Science and Business Media LLC,c 2011 |
338 | a electronic2 rdacarrier | |
520 | a Introduction: Proteins encoded by Fanconi anemia (FA) and/or breast cancer (BrCa) susceptibility genes cooperate in a common DNA damage repair signaling pathway. To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens. Methods: Protein physical interactions were screened using the yeast two-hybrid system. Co-affinity purifications and endogenous co-immunoprecipitation assays were performed to corroborate interactions. Biochemical and functional assays in human, mouse and Caenorhabditis elegans models were carried out to characterize pathway components. Thirteen FANCD2-monoubiquitinylation-positive FA cell lines excluded for genetic defects in the downstream pathway components and 300 familial BrCa patients negative for BRCA1/2 mutations were analyzed for genetic mutations. Common genetic variants were genotyped in 9,573 BRCA1/2 mutation carriers for associations with BrCa risk. Results: A previously identified co-purifying protein with PALB2 was identified, MRG15 (MORF4L1 gene). Results in human, mouse and C. elegans models delineate molecular and functional relationships with BRCA2, PALB2, RAD51 and RPA1 that suggest a role for MRG15 in the repair of DNA double-strand breaks. Mrg15-deficient murine embryonic fibroblasts showed moderate sensitivity to g-irradiation relative to controls and reduced formation of Rad51 nuclear foci. Examination of mutants of MRG15 and BRCA2 C. elegans orthologs revealed phenocopy by accumulation of RPA-1 (human RPA1) nuclear foci and aberrant chromosomal compactions in meiotic cells. However, no alterations or mutations were identified for MRG15/MORF4L1 in unclassified FA patients and BrCa familial cases. Finally, no significant associations between common MORF4L1 variants and BrCa risk for BRCA1 or BRCA2 mutation carriers were identified: rs7164529, P-trend = 0.45 and 0.05, P-2df = 0.51 and 0.14, respectively; and rs10519219, P-trend = 0.92 and 0.72, P-2df = 0.76 and 0.07, respectively. Conclusions: While the present study expands on the role of MRG15 in the control of genomic stability, weak associations cannot be ruled out for potential low-penetrance variants at MORF4L1 and BrCa risk among BRCA2 mutation carriers. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
653 | a Rad51 Recombinase | |
653 | a RNA Interference | |
653 | a Nuclear Proteins | |
653 | a Mutation | |
653 | a Mice | |
653 | a Humans | |
653 | a Genetic Predisposition to Disease | |
653 | a BRCA2 | |
653 | a BRCA1 | |
653 | a Genes | |
653 | a Female | |
653 | a Fanconi Anemia Complementation Group D2 Protein | |
653 | a Fanconi Anemia | |
653 | a DNA Repair | |
653 | a DNA Damage | |
653 | a Cell Line | |
653 | a Caenorhabditis elegans | |
653 | a Animals | |
653 | a Breast Neoplasms | |
653 | a Replication Protein A | |
653 | a Risk Factors | |
653 | a Transcription Factors | |
653 | a Tumor Suppressor Proteins | |
653 | a Two-Hybrid System Techniques | |
653 | a MEDICINE | |
653 | a TECHNOLOGY | |
700 | 1 | a Maxwell, Christopher A.u IDIBELL4 aut |
700 | 1 | a Tominaga, Emikou University of Texas Health Science Centre San Antonio4 aut |
700 | 1 | a Porta-de-la-Riva, Montserratu Chemoresistance and Predictive Factors of Tumor Response and Stromal Microenvironment, IDIBELL, Spain4 aut |
700 | 1 | a Bonifaci, Nuriau IDIBELL4 aut |
700 | 1 | a Gomez-Baldo, Laiau IDIBELL4 aut |
700 | 1 | a Bogliolo, Massimou Autonomous University Barcelona4 aut |
700 | 1 | a Lazaro, Conxiu IDIBELL4 aut |
700 | 1 | a Blanco, Ignaciou IDIBELL4 aut |
700 | 1 | a Brunet, Joanu Hospital Josep Trueta4 aut |
700 | 1 | a Aguilar, Helenau Bellvitge Institute Biomed Research IDIBELL4 aut |
700 | 1 | a Fernandez-Rodriguez, Juanau IDIBELL4 aut |
700 | 1 | a Seal, Sheilau Institute Canc Research4 aut |
700 | 1 | a Renwick, Anthonyu Institute Canc Research4 aut |
700 | 1 | a Rahman, Nazneenu Institute Canc Research4 aut |
700 | 1 | a Kuehl, Juliau Department of Human Genetics, University of Würzburg, Biozentrum, Am Hubland, Würzburg, Germany4 aut |
700 | 1 | a Neveling, Korneliau University Wurzburg4 aut |
700 | 1 | a Schindler, Detlevu University Wurzbur4 aut |
700 | 1 | a Ramirez, Maria J.u Autonomous University Barcelona4 aut |
700 | 1 | a Castella, Mariau Autonomous University Barcelon4 aut |
700 | 1 | a Hernandez, Gonzalou Autonomous University Barcelona4 aut |
700 | 1 | a Easton, Douglas F.u University Cambridge,Newcastle Upon Tyne Hospital NHS Trust4 aut |
700 | 1 | a Peock, Susanu University Cambridge4 aut |
700 | 1 | a Cook, Margaretu University Cambridge4 aut |
700 | 1 | a Oliver, Clare T.u University Cambridge4 aut |
700 | 1 | a Frost, Debrau University Cambridge4 aut |
700 | 1 | a Platte, Radkau University Cambridge4 aut |
700 | 1 | a Evans, D. Garethu Cent Manchester University Hospital NHS Fdn Trust4 aut |
700 | 1 | a Lalloo, Fionau Cent Manchester University Hospital NHS Fdn Trust4 aut |
700 | 1 | a Eeles, Rosalindu Institute Canc Research, Oncogenet Team4 aut |
700 | 1 | a Izatt, Louiseu Guys and St Thomas NHS Fdn Trust4 aut |
700 | 1 | a Chu, Carolu St James Hospital,University Cambridge4 aut |
700 | 1 | a Davidson, Rosemarieu Ferguson Smith Centre Clin Genet4 aut |
700 | 1 | a Ong, Kai-Renu Birmingham Womens Hospital Healthcare NHS Trust4 aut |
700 | 1 | a Cook, Jackieu Sheffield Childrens Hospital4 aut |
700 | 1 | a Douglas, Fiona4 aut |
700 | 1 | a Hodgson, Shirleyu University London4 aut |
700 | 1 | a Brewer, Caroleu Royal Devon and Exeter Hospital4 aut |
700 | 1 | a Morrison, Patrick J.u Belfast City Hospital4 aut |
700 | 1 | a Porteous, Maryu Western Gen Hospital4 aut |
700 | 1 | a Peterlongo, Paolou Fdn IRCCS Ist Nazl Tumori INT,Leiden University4 aut |
700 | 1 | a Manoukian, Siranoushu Fdn IRCCS INT4 aut |
700 | 1 | a Peissel, Bernardu Fdn IRCCS INT4 aut |
700 | 1 | a Zaffaroni, Danielau Fdn IRCCS INT4 aut |
700 | 1 | a Roversi, Gaiau Fdn IRCCS INT4 aut |
700 | 1 | a Barile, Monicau Ist Europeo Oncol IEO4 aut |
700 | 1 | a Viel, Alessandrau IRCCS4 aut |
700 | 1 | a Pasini, Barbarau University Turin4 aut |
700 | 1 | a Ottini, Laurau University Roma La Sapienza4 aut |
700 | 1 | a Putignano, Anna Laurau Fiorgen Fdn Pharmacogen4 aut |
700 | 1 | a Savarese, Antonellau Regina Elena Institute Canc Research4 aut |
700 | 1 | a Bernard, Lorisu IEO,Netherlands Canc Institute4 aut |
700 | 1 | a Radice, Paolou Fdn IRCCS Ist Nazl Tumori INT4 aut |
700 | 1 | a Healey, Sueu Queensland Institute Med Research4 aut |
700 | 1 | a Spurdle, Amandau Queensland Institute Med Research4 aut |
700 | 1 | a Chen, Xiaoqingu Queensland Institute Med Research4 aut |
700 | 1 | a Beesley, Jonathanu Queensland Institute Med Research4 aut |
700 | 1 | a Rookus, Matti A.u Netherlands Canc Institute4 aut |
700 | 1 | a Verhoef, Sennou Netherlands Canc Institute4 aut |
700 | 1 | a Tilanus-Linthorst, Madeleine A.u Erasmus MC Daniel den Hoed Canc Centre4 aut |
700 | 1 | a Vreeswijk, Maaike P.4 aut |
700 | 1 | a Asperen, Christi J.u Leiden University4 aut |
700 | 1 | a Bodmer, Danielleu Radboud University Nijmegen4 aut |
700 | 1 | a Ausems, Margreet G. E. M.4 aut |
700 | 1 | a van Os, Theo A.u University Amsterdam4 aut |
700 | 1 | a Blok, Marinus J.u University Hospital Maastricht4 aut |
700 | 1 | a Meijers-Heijboer, Hanne E. J.u Vrije University Amsterdam Med Centre,Canc Prevent Institute Calif4 aut |
700 | 1 | a Hogervorst, Frans B. L.4 aut |
700 | 1 | a Goldgar, David E.u University Utah4 aut |
700 | 1 | a Buys, Saundrau Huntsman Canc Institute4 aut |
700 | 1 | a John, Esther M.4 aut |
700 | 1 | a Miron, Alexanderu Harvard University4 aut |
700 | 1 | a Southey, Melissau University Melbourne4 aut |
700 | 1 | a Daly, Mary B.u Fox Chase Canc Centre4 aut |
700 | 1 | a Harbst, Katjau Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Skane University Hospital4 aut0 (Swepub:lu)med-kbn |
700 | 1 | a Borg, Åkeu Lund University,Lunds universitet,Bröstcancer-genetik,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Breastcancer-genetics,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Skane University Hospital4 aut0 (Swepub:lu)onk-abo |
700 | 1 | a Rantala, Johannau Karolinska Institutet,Karolinska University Hospital4 aut |
700 | 1 | a Barbany-Bustinza, Giselau Karolinska Institutet,Karolinska University Hospital4 aut |
700 | 1 | a Ehrencrona, Hansu Uppsala universitet,Uppsala University,Institutionen för immunologi, genetik och patologi4 aut0 (Swepub:lu)med-hen |
700 | 1 | a Stenmark Askmalm, Marieu Östergötlands Läns Landsting,Linköpings universitet,Onkologi,Hälsouniversitetet,Klinisk patologi och klinisk genetik4 aut0 (Swepub:liu)marst93 |
700 | 1 | a Kaufman, Bellau The Institute of Oncology, Chaim Sheba Medical Center, Israel4 aut |
700 | 1 | a Laitman, Yaelu Chaim Sheba Med Centre4 aut |
700 | 1 | a Milgrom, Roniu Chaim Sheba Med Centre4 aut |
700 | 1 | a Friedman, Eitanu Chaim Sheba Med Centre4 aut |
700 | 1 | a Domchek, Susan M.u University Penn4 aut |
700 | 1 | a Nathanson, Katherine L.u University Penn4 aut |
700 | 1 | a Rebbeck, Timothy R.u University Penn4 aut |
700 | 1 | a Johannsson, Oskar Thoru Department of Oncology, 20A Landspitali-LSH v/Hringbraut, Reykjavik, Iceland4 aut |
700 | 1 | a Couch, Fergus J.u Mayo Clin4 aut |
700 | 1 | a Wang, Xianshuu Mayo Clin4 aut |
700 | 1 | a Fredericksen, Zacharyu Mayo Clin4 aut |
700 | 1 | a Cuadras, Danielu IDIBELL4 aut |
700 | 1 | a Moreno, Vctoru IDIBELL4 aut |
700 | 1 | a Pientka, Friederike K.u University Lubeck4 aut |
700 | 1 | a Depping, Reinhardu University Lubeck4 aut |
700 | 1 | a Caldes, Trinidadu Hospital Clin San Carlos4 aut |
700 | 1 | a Osorio, Anau Spanish Natl Canc Research Centre4 aut |
700 | 1 | a Benitez, Javieru Spanish Natl Canc Research Centre4 aut |
700 | 1 | a Bueren, Juanu Centre Invest Energet Medioambientales and Tecnol CIEM,4 aut |
700 | 1 | a Heikkinen, Tuomasu University Helsinki4 aut |
700 | 1 | a Nevanlinna, Heliu University Helsinki4 aut |
700 | 1 | a Hamann, Uteu Deutsch Krebsforschungszentrum DKFZ4 aut |
700 | 1 | a Torres, Dianau Pontificia University Javeriana4 aut |
700 | 1 | a Caligo, Maria Adelaideu University Hospital Pisa4 aut |
700 | 1 | a Godwin, Andrew K.u University Kansas4 aut |
700 | 1 | a Imyanitov, Evgeny N.u NN Petrov Oncol Research Institute4 aut |
700 | 1 | a Janavicius, Ramunasu Vilnius University Hospital4 aut |
700 | 1 | a Sinilnikova, Olga M.u University Lyon 14 aut |
700 | 1 | a Stoppa-Lyonnet, Dominiqueu Institute Curie4 aut |
700 | 1 | a Mazoyer, Sylvieu University Lyon 14 aut |
700 | 1 | a Verny-Pierre, Caroleu University Lyon 14 aut |
700 | 1 | a Castera, Laurentu Institute Curie4 aut |
700 | 1 | a de Pauw, Antoineu Institute Curie4 aut |
700 | 1 | a Bignon, Yves-Jeanu University Clermont Ferrand4 aut |
700 | 1 | a Uhrhammer, Nancyu University Clermont Ferrand4 aut |
700 | 1 | a Peyrat, Jean-Philippeu Centre Oscar Lambret4 aut |
700 | 1 | a Vennin, Philippeu Consultation d'Oncogénétique, Centre Oscar Lambret, Lille, France4 aut |
700 | 1 | a Ferrer, Sandra Fertu Hotel Dieu Centre Hospital4 aut |
700 | 1 | a Collonge-Rame, Marie-Agnesu CHU Besancon4 aut |
700 | 1 | a Mortemousque, Isabelleu CHU Bretonneau4 aut |
700 | 1 | a McGuffog, Lesleyu University Cambridge4 aut |
700 | 1 | a Chenevix-Trench, Georgiau Queensland Institute Med Research4 aut |
700 | 1 | a Pereira-Smith, Olivia M.u University Texas Hlth Science Centre San Antonio4 aut |
700 | 1 | a Antoniou, Antonis C.4 aut |
700 | 1 | a Ceron, Julianu IDIBELL4 aut |
700 | 1 | a Tominaga, Kaoruu University Texas Hlth Science Centre San Antonio4 aut |
700 | 1 | a Surralles, Jordiu Autonomous University Barcelona4 aut |
700 | 1 | a Angel Pujana, Miguelu Catalan Institute of Oncology, IDIBELL, Spain4 aut |
710 | 2 | a IDIBELLb University Med Centre Utrecht4 org |
773 | 0 | t Breast Cancer Researchd : Springer Science and Business Media LLCg 13:2q 13:2x 1465-5411x 1465-542X |
856 | 4 | u https://portal.research.lu.se/files/2156604/2224138.pdfx primaryx freey FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1186/bcr2862x freey FULLTEXT |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/21466675x freey FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1186/bcr2862x freey FULLTEXT |
856 | 4 | u https://breast-cancer-research.biomedcentral.com/track/pdf/10.1186/bcr2862 |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:433157/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://lup.lub.lu.se/record/2094273 |
856 | 4 8 | u https://doi.org/10.1186/bcr2862 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:122911763 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-156692 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-69933 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy